MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/liv.70437

Медицинская библиотека · Liver international : official journal of the International Association for the Study of the Liver · 2025

Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study.

Iavarone Massimo, Alimenti Eleonora, Puoti Massimo, Hasson Hamid, Monti Bianca, Bhoori Sherrie, Peracchi Francesco, Siribelli Alessia, Fava Marco, Bruccoleri Mariangela, Merli Marco, Morsica Giulia, De Silvestri Annalisa, Bonfanti Paolo, Castagna Antonella, Soria Alessandro, Lampertico Pietro

СтатьяМногоцентровое исследованиеСравнительное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND AND AIMS: Conflicting data on hepatocellular carcinoma (HCC) survival in people with HIV (PWH) may depend on tumour aggressiveness and access to curative treatments. We compared outcomes of two HCC cohorts according to HIV status.

METHODS

Patients from four tertiary referral centers in Northern Italy with the first HCC diagnosis (2005-2023) were analysed. Clinical characteristics, treatment access, and overall survival (OS) were described by HIV status, using inverse probability treatment weighting and propensity score (IPTW/PS) methods. Cox regression models assessed mortality predictors and recurrence after initial treatment.

RESULTS

Among 606 patients, 143 were PWH and 463 HIV-negative. PWH were younger (median age 53 vs. 68 years, p < 0.001), predominantly male (87% vs. 75%, p = 0.004), with a lower proportion of Child-Pugh A cirrhosis (71% vs. 76%, p = 0.01). Despite similar surveillance rates (91% vs. 88%), PWH more frequently presented with BCLC-C stage HCC (22% vs. 10%, p < 0.001). First-line curative treatments were offered to 47% of PWH and 60% of HIV-negative patients (p = 0.006), while second-line treatment rates were similar (42% vs. 44%, p = 0.91). During median follow-up of 32 (11-78) and 36 (19-84) months for PWH and HIV-negative subjects (p = 0.04), five-year OS was 43.4% versus 44.1% (p = 0.97), median OS was 48 [interquartile range (IQR) 15-127] versus 46 (IQR 21-109) months (p = 0.97). Multivariable analysis after IPTW/PS showed similar mortality (HR 1.03, 95% CI 0.52-1.99, p = 0.94) but a higher two-year recurrence rate in PWH (47.4% vs. 22.8%, p = 0.03).

CONCLUSION

Despite more advanced tumours and higher recurrence, survival in PWH with HCC was similar. Access to curative treatments with aggressive downstaging strategies may counterbalance initial disadvantages.

Для цитирования: Iavarone Massimo, Alimenti Eleonora, Puoti Massimo, Hasson Hamid, Monti Bianca, Bhoori Sherrie, Peracchi Francesco, Siribelli Alessia, Fava Marco, Bruccoleri Mariangela, Merli Marco, Morsica Giulia, De Silvestri Annalisa, Bonfanti Paolo, Castagna Antonella, Soria Alessandro, Lampertico Pietro. Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study.. Liver international : official journal of the International Association for the Study of the Liver. 2025. DOI: 10.1111/liv.70437.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.